On 3rd December 2021, the NHS Research Scotland Neuroprogressive and Dementia Research Network (NRS NDN) launched a new strategy. It sets out the Network’s intention to involve, engage with, and support people with lived experience of neuroprogressive...
Scottish Neurological Research Fund Announcement Earlier this year, the Scottish Neurological Research Fund (SNRF) launched a second round of funding, following its success in 2019. The scheme provides up to £15,000 of funding per application for small...
Researchers Glasgow Brain Injury Research Group (GBIRG) led by Associate Professor Willie Stewart, have published their findings reporting a link between a footballers’ outfield position and neurodegenerative risk. Taking place at the University of Glasgow, as...
Today (8 July 2021) sees the launch of the first Scottish Brain Health & Dementia Research Strategy. Prepared by Alzheimer Scotland, The Scottish Dementia Research Consortium and Brain Health Scotland, and endorsed by a broad range of national organisations, the...
The SDRC Annual Report 2020/21, launched at the SDRC Annual Conference 2021 on Wednesday 16th June. It outlines what research has been ongoing in dementia and brain health research in Scotland in the past 12 months. Of course, it heavily features the impact COVID has...
Aducanumab: Dr Terry Quinn explains approval of new Alzheimer’s disease drug SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the...